SNAP-8 vs Argireline

SNAP-8 is Argireline extended by two amino acids, built on the same idea: mimic part of SNAP-25 to interfere with the SNARE complex that drives nerve-to-muscle signalling. The longer chain was designed to compete more effectively, but published human data test both inside multi-ingredient formulas.

HPLC tested · JanoshikJanoshik CertificatesNationwide DeliveryResearch Only

🧪

SNAP-8

An eight-amino-acid extension of Argireline, designed as a topical expression-line peptide that targets the same SNARE complex.

BEST STUDIED FOR

Skin peptides

Read the cited profile →

🧪

Argireline

A synthetic hexapeptide patterned on the N-terminus of SNAP-25, studied as a topical "Botox-like" anti-wrinkle ingredient.

BEST STUDIED FOR

Skin peptides

Read the cited profile →

SIDE BY SIDE

	SNAP-8	Argireline
The key difference	Eight amino acids	Six amino acids
Class	Skin peptides	Skin peptides
Mechanism	Like Argireline, SNAP-8 mimics part of the SNAP-25 protein and is proposed to interfere with assembly of the SNARE complex, the machinery that releases neurotransmitter at the nerve–muscle junction.	Argireline competes with SNAP-25 for a place in the SNARE complex, the protein machinery that releases neurotransmitter at the neuromuscular junction.
Status	A cosmetic ingredient. Published human studies test it inside multi-ingredient formulas (often Korean microneedle-patch products), so its stand-alone effect is not isolated.	A widely used cosmetic ingredient with several small clinical studies; skin penetration is a recognised limitation.
Reported safety signals	Patch studies that included it reported good dermal tolerability; systemic data do not exist because it is a topical cosmetic ingredient.	Topical studies report it as well tolerated; it is far less potent than botulinum toxin, which is the safety rationale for its design.
A key study	The parent peptide: Argireline was designed to interfere with SNARE-complex formation and showed anti-wrinkle activity in an emulsion study. (Int J Cosmet Sci 2002, PMID 18498523)	Describes Argireline’s design as a SNARE-complex-inhibiting peptide and its anti-wrinkle activity. (Int J Cosmet Sci 2002, PMID 18498523)

WHEN TO RESEARCH WHICH

Argireline has the deeper stand-alone literature; SNAP-8 is its longer, newer sibling. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.

REFERENCES (PUBMED)

[SNAP-8] A synthetic hexapeptide (Argireline) with antiwrinkle activity — Int J Cosmet Sci 2002. PMID 18498523
[SNAP-8] Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study — J Cosmet Dermatol 2020. PMID 31134751
[SNAP-8] Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities — Ann Dermatol 2024. PMID 39082657
[Argireline] A synthetic hexapeptide (Argireline) with antiwrinkle activity — Int J Cosmet Sci 2002. PMID 18498523
[Argireline] The anti-wrinkle efficacy of Argireline — J Cosmet Laser Ther 2013. PMID 23464592
[Argireline] Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow’s Feet — J Clin Aesthet Dermatol 2023. PMID 36909866

FREQUENTLY ASKED

What is the difference between SNAP-8 and Argireline?

What is the regulatory status of SNAP-8 and Argireline?

SNAP-8: A cosmetic ingredient. Published human studies test it inside multi-ingredient formulas (often Korean microneedle-patch products), so its stand-alone effect is not isolated. Argireline: A widely used cosmetic ingredient with several small clinical studies; skin penetration is a recognised limitation.

What safety signals have been reported?

SNAP-8: Patch studies that included it reported good dermal tolerability; systemic data do not exist because it is a topical cosmetic ingredient. Argireline: Topical studies report it as well tolerated; it is far less potent than botulinum toxin, which is the safety rationale for its design.

Which studies is this comparison based on?

For SNAP-8: “A synthetic hexapeptide (Argireline) with antiwrinkle activity” (PMID 18498523); “Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study” (PMID 31134751); “Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities” (PMID 39082657). For Argireline: “A synthetic hexapeptide (Argireline) with antiwrinkle activity” (PMID 18498523); “The anti-wrinkle efficacy of Argireline” (PMID 23464592); “Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow’s Feet” (PMID 36909866).